Therapeutic targeting of FLT3 and associated drug resistance in acute myeloid leukemia

Overview of attention for article published in Journal of Hematology & Oncology, November 2020

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (80th percentile)
Above-average Attention Score compared to outputs of the same age and source (58th percentile)

Mentioned by

blogs: 1 blog

twitter: 3 X users

Citations

dimensions_citation: 42 Dimensions

Readers on

mendeley: 47 Mendeley

Summary Blogs X Dimensions citations

So far, Altmetric has seen 1 blog post.

PCW-A1001, AI-assisted de novo design approach to design a selective inhibitor for FLT-3(D835Y) in acute myeloid leukemia

Computational Chemistry Daily, 09 Dec 2022

frontiersin.org - Treating acute myeloid leukemia (AML) by targeting FMS-like tyrosine kinase 3 (FLT-3) is considered an…

This page shows the most recent blog posts that mention this research output.

Click here to find out how to access more activity.